Demo Sign up Log In

Esperion Therapeutics Inc (ESPR)

Income Tax Expense

$0.00

Quarterly · Period ending: Mar 31, 2026 · USD

ESPR Income Tax Expense

Latest reported$0.00period endingMar 31, 2026

Latest reported$0.00period endingMar 31, 2026

ESPR Quarterly Income Tax (-$375.92K → $0.00)

Quarterly income tax expense

High-resolution chart · PNG

ESPR income tax expense history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc Income Tax Expense — Quarterly (USD)
Period ending	Income Tax Expense (USD)
Mar 31, 2026	0
Dec 31, 2025	1,841,000
Sep 30, 2025	0
Jun 30, 2025	0
Mar 31, 2025	0
Dec 31, 2024	0
Sep 30, 2024	0
Jun 30, 2024	0
Mar 31, 2024	0
Dec 31, 2023	0
Sep 30, 2023	0
Jun 30, 2023	0
Mar 31, 2023	0
Dec 31, 2022	0
Sep 30, 2022	0
Jun 30, 2022	0
Mar 31, 2022	0
Dec 31, 2021	0
Sep 30, 2021	0
Jun 30, 2021	0
Mar 31, 2021	0
Dec 31, 2020	0
Sep 30, 2020	0
Jun 30, 2020	0
Mar 31, 2020	0
Dec 31, 2019	0
Sep 30, 2019	0
Jun 30, 2019	0
Mar 31, 2019	0
Dec 31, 2018	-74,000
Sep 30, 2018	0
Jun 30, 2018	0
Mar 31, 2018	0
Dec 31, 2017	0
Sep 30, 2017	0
Jun 30, 2017	433,000
Mar 31, 2017	0
Dec 31, 2016	0
Sep 30, 2016	0
Jun 30, 2016	0
Mar 31, 2016	0
Dec 31, 2015	0
Sep 30, 2015	0
Jun 30, 2015	0
Mar 31, 2015	0
Dec 31, 2014	0
Sep 30, 2014	0
Jun 30, 2014	18,000
Mar 31, 2014	16,000
Dec 31, 2013	46,570
Sep 30, 2013	168,389
Jun 30, 2013	112,392
Mar 31, 2013	803,239
Dec 31, 2012	0
Sep 30, 2012	0
Jun 30, 2012	0
Mar 31, 2012	0
Sep 30, 2003	0
Jun 30, 2003	0
Mar 31, 2003	0
Dec 31, 2002	0
Sep 30, 2002	0
Jun 30, 2002	0
Mar 31, 2002	0
Dec 31, 2001	0
Sep 30, 2001	0
Jun 30, 2001	0
Mar 31, 2001	0
Dec 31, 2000	-1,233,000
Sep 30, 2000	3,556,000
Jun 30, 2000	-308,056
Mar 31, 2000	-375,920

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.